Items where Author is "Cappellini, Maria Domenica"
 | Up a level |
Conference or Workshop Item
Locatelli, Franco and Frangoul, Haydar and Corbacioglu, Selim and de la Fuente, Josu and Wall, Donna and Cappellini, Maria Domenica and de Montalembert, Mariane and Kattamis, Antonis and Lobitz, Stephan and Rondelli, Damiano and Sheth, Sujit and Steinberg, Martin and Walters, Mark C. and Bobruff, Yael and Simard, Chris and Song, Yang and Zhang, Lanju and Sharma, Anjali and Imren, Suzan and Hobbs, Bill and Grupp, Stephan (2023) EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT.-THALASSEMIA AND SEVERE SICKLE CELL DISEASE. In: 49th Annual Annual Meeting of the European Society for Blood and Marrow Transplantation, 23 - 26 April, 2023, Hybrid Meeting.
de la Fuente, Josu and Frangoul, Haydar and Bobruff, Yael and Cappellini, Maria Domenica and Corbacioglu, Selim and Fernandez, Christine Marie and Grupp, Stephan and Handgretinger, Rupert and Ho, Tony W. and Imren, Suzan and Kattamis, Antonis and Lekstrom-Himes, Julie and Locatelli, Franco and Lu, Yimeng and Mapara, Markus and Mulcahey, Sarah and de Montalembert, Mariane and Rondelli, Damiano and Shanbhag, Niraj and Sheth, Sujit and Soni, Sandeep and Steinberg, Martin H. and Weinstein, Michael and Wu, John and Wall, Donna (2021) Early safety and efficacy results with a single dose of autologous CRISPR-Cas9-modified CD34+hematopoietic stem and progenitor cells in transfusion-dependent beta-thalassemia and sickle cell disease. In: 61st Annual Scientific Meeting of the British Society for Haematology, 25 – 28 April 2021, Virtual.
Other
Frangoul, Haydar and Locatelli, Franco and Corbacioglu, Selim and De La Fuente, Josu and Wall, Donna and Cappellini, Maria Domenica and de Montalembert, Mariane and Kattamis, Antonis and Lobitz, Stephan and Rondelli, Damiano and Sheth, Sujit and Steinberg, Martin and Walters, Mark and Bobruff, Yael and Simard, Chris and Song, Yang and Zhang, Lanju and Sharma, Anjali and Imren, Suzan and Hobbs, Bill and Grupp, Stephan A. (2023) Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease. CELL PRESS, CAMBRIDGE.
